IceCure Medical (ICCM) Retained Earnings (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Retained Earnings data on file, last reported at -$124.7 million in Q1 2026.

• Retained Earnings for Q1 2026 came in at -$124.7 million, down 14.45% year-over-year; the trailing twelve-month figure through Mar 2026 was -$124.7 million (down 14.45% YoY), and the FY2025 annual result was -$120.4 million, down 14.29% from the prior year.
• Retained Earnings retreated to -$124.7 million in Q1 2026 per ICCM's latest filing, from -$120.4 million in the prior quarter.
• Over five years, Retained Earnings peaked at -$62.9 million in Q1 2022 and troughed at -$75.4 billion in Q4 2022.
• A 5-year average of -$4.5 billion and a median of -$96.8 million in 2024 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2022 and 2023: Retained Earnings sank 128956.49% in 2022, then soared 99.88% in 2023.
• A 5-year view of Retained Earnings shows it stood at -$75.4 billion in 2022, then soared by 99.88% to -$90.1 million in 2023, then slipped by 17.01% to -$105.4 million in 2024, then declined by 14.29% to -$120.4 million in 2025, then dropped by 3.55% to -$124.7 million in 2026.
• Business Quant data shows ICCM's Retained Earnings at -$124.7 million in Q1 2026, -$120.4 million in Q4 2025, and -$116.2 million in Q3 2025.